Case Report
V Chauhan, M Chauhan
Immune Thrombocytopenia (ITP) is an autoimmune disorder that can be characterised by immune-mediated destruction of platelets that leads to an increased risk of bleeding. Platelets are responsible for blood clotting. In this condition, the platelet count is low, which leads to easy bruising, red or purple spots (Petechiae), nasal or gum bleeding, heavy menstrual bleeding etc. According to Ayurvedic principles, Immune Thrombocytopenia (ITP) can be correlated with Tiryakgata Raktapitta, a Tridoshic disorder with predominant involvement of Pitta Dosha. Due to the severity of this condition, it is considered under Ashta Mahagadas (eight major diseases) in Ayurveda texts. According to Ayurveda, Raktapitta develops when aggravated Pitta Dosha vitiates the blood (Rakta), increasing its quantity and causing it to flow abnormally through different body channels. Based on the direction of bleeding, Raktapitta is classified into three types: Urdhvaga, where bleeding occurs from the upper orifices such as the nose, mouth, ears, and eyes; Adhoga, where bleeding occurs from the lower passages including the anus, urinary tract, and genital tract; and Tiryakgata, in which vitiated blood spreads through the skin and subcutaneous tissues, producing hemorrhagic manifestations. In this study, we will discuss a case of a 52-year-old female who had Immune Thrombocytopenia (ITP), which was managed by Ayurvedic formulations.
Original Article
Tariqul Islam MD
Background: Irritable Bowel Syndrome (IBS) is a prevalent functional gastrointestinal disorder characterized by abdominal pain, altered bowel habits, bloating, and food intolerances, significantly impairing quality of life. Conventional management primarily offers transient symptomatic relief. Targeted homeopathic protocols and bowel nosodes present a potential noninvasive, structured therapeutic option. This retrospective case series evaluates the clinical symptom resolution and dietary tolerance recovery in patients with IBS undergoing a combined homeopathic protocol alongside dietary advice. Methods: A retrospective analysis was conducted on 30 patients presenting with IBS-M (Mixed) and IBS-D (Diarrhea-predominant with dysenteric features) diagnosed per Rome IV criteria. Symptoms included frequent evacuation (3–4 times daily), incomplete clearance, mucus-laden stools, dairy/lipid intolerances, and concurrent gastritis. Patients were evaluated over a 3-month period receiving a paired remedy protocol (Mercurius vivus 200C, Chelidonium majus 30C, Mercurius solubilis 6C, Ipecacuanha 30C, Dysentery Compound 30C, and Nux Vomica 30C) alongside a structured 4-week initial trigger food avoidance (Low-FODMAP guidance) followed by gradual reintroduction. Results: High rates of clinical symptom resolution were observed across all 30 patients within the 12-week timeframe. Stool frequency normalized to 1–2 evacuations daily, rectal tenesmus resolved, and epigastric discomfort was alleviated. Furthermore, oral tolerance to previously restricted foods (milk, fatty meals, leafy greens) was successfully restored without reported adverse events. Conclusion: The observational findings suggest that structured homeopathic protocols paired with bowel nosodes and lifestyle/dietary guidance may serve as a beneficial adjunct management strategy in IBS. Given the retrospective and uncontrolled design, prospective randomized controlled trials (RCTs) are warranted to evaluate causality and long-term efficacy.
